Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study by Helvoort, H.A.C. van et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
ARTICLE OPEN
Respiratory constraints during activities in daily life and the
impact on health status in patients with early-stage COPD:
a cross-sectional study
Hanneke AC van Helvoort1,2,3, Laura M Willems1,2,3, PN Richard Dekhuijzen1, Hieronymus WH van Hees1,2 and Yvonne F Heijdra1
In patients with chronic obstructive pulmonary disease (COPD), exercise capacity is reduced, resulting over time in physical
inactivity and worsened health status. It is unknown whether ventilatory constraints occur during activities of daily life (ADL) in early
stages of COPD. The aim of this study was to assess respiratory mechanics during ADL and to study its consequences on dyspnoea,
physical activity and health status in early-stage COPD compared with healthy controls. In this cross-sectional study, 39 early-stage
COPD patients (mean FEV1 88 ± s.d. 12% predicted) and 20 controls performed 3 ADL: climbing stairs, vacuum cleaning and
displacing groceries in a cupboard. Respiratory mechanics were measured during ADL. Physical activity was measured with
accelerometry. Health status was assessed by the Nijmegen Clinical Screening Instrument. Compared with controls, COPD patients
had greater ventilatory inefﬁciency and higher ventilatory requirements during ADL (Po0.05). Dyspnoea scores were increased in
COPD compared with controls (Po0.001). During ADL, 450% of the patients developed dynamic hyperinﬂation in contrast to
10–35% of the controls. Higher dyspnoea was scored by patients with dynamic hyperinﬂation. Physical activity was low but
comparable between both groups. From the patients, 55–84% experienced mild-to-severe problems in health status compared
with 5–25% of the controls. Signiﬁcant ventilatory constraints already occur in early-stage COPD patients during common ADL and
result in increased dyspnoea. Physical activity level is not yet reduced, but many patients already experience limitations in health
status. These ﬁndings reinforce the importance of early diagnosis of COPD and assessment of more than just spirometry.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is characterised by
chronic inﬂammation of the airways and lungs, persistent airﬂow
limitation and, often, a progressive decline in lung function.
Nowadays, it is associated with multiple and signiﬁcant morbidity
and increased mortality.1 Despite this prospect, COPD remains
often undiagnosed and untreated until the disease has progressed
to a point where lung function and quality of life are severely
affected.2
Many had or still have the perception that mild airway
obstruction (i.e., post-bronchodilator forced expiratory ﬂow in 1 s
(FEV1)/forced vital capacity o0.7 and FEV1 480% predicted) has
few clinical consequences and does not require intervention.
However, there is growing evidence that even mild airway
obstruction is associated with a reduction in exercise capacity
and physical activity in patients with COPD.3–6 Even before
patients are aware of their illness, they often evade some of their
(more strenuous) activities to avoid unpleasant symptoms, such as
dyspnoea. This can, over time, lead to a negative spiral of
worsening symptoms, deconditioning and exercise intolerance, as
patients become progressively more sedentary.7,8
An understanding of the structure–function relationships in the
lungs and airways may assist in understanding exercise limitations,
also in early stages of COPD. A range of structural abnormalities,
including airway wall thickening, pulmonary gas trapping,
emphysema and vascular dysfunction,9–11 contribute to high
ventilatory demands5,12,13 and impairment of dynamic respiratory
mechanics in patients with COPD. These mechanisms of exercise
limitations have all been extended to patients with mild
COPD,5,9,12 indicating that the respiratory system reaches its
physiological limits at the end of (strenuous) exercise. Further-
more, cardiocirculatory impairment14–16 and skeletal muscle
dysfunction17–20 have been reported in mild-to-moderate COPD,
and may, in turn, also lead to reduced exercise capacity and
activity limitation. However, it remains unclear as to which of all
the mentioned mechanisms, and to what extent, actually
contributes to respiratory system limitations during activities of
daily life(ADL), as these activities are normally much less strenuous
than exercise tests.
In the current study, respiratory mechanics during different ADL
were investigated in COPD patients with relatively preserved
airﬂow, deﬁned here as early-stage COPD (FEV1465% predicted).
Healthy control subjects were used for comparison. The aim was
to investigate whether changes in respiratory mechanics (i.e., high
ventilatory demands and dynamic hyperinﬂation (Figure 1)) also
occur in early-stage COPD during common ADL and thereby result
in more dyspnoea. Because of the potential role of respiratory
limitations for important clinical outcomes such as dyspnoea,
physical activity and health status, it was also cross-sectionally
investigated whether these outcomes indeed were affected in
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early-stage COPD compared with healthy controls. The measure-
ment of respiratory mechanics (i.e., dynamic hyperinﬂation)
especially during ADL makes this study unique and additional to
other results presented in the literature in this ﬁeld.
RESULTS
Subjects
General characteristics and pulmonary function data are prese-
nted in Table 1. COPD patients did smoke more pack-years and
experienced more dyspnoea on the MRC scale compared with
healthy controls.
Physiology and respiratory mechanics during ADL
Table 2 shows the physiological response to all three ADL for
patients and controls. Although oxygen uptake was comparable
for patients and controls in each activity, ventilation was signi-
ﬁcantly higher in patients with COPD. In addition, COPD patients
had greater ventilator inefﬁciency compared with controls in all
three ADL. BORG dyspnoea scores at end ADL were increased in
COPD patients compared with controls. None of the subjects
reached ventilation levels higher than 85% of predicted maximal
voluntary ventilation during ADL. Mean change in IC was negative
in patients but positive in controls. Mean inspiratory reserve
volume (IRV) was preserved.
Figure 2 shows the metabolic and ventilatory responses to one
of the ADL, namely vacuum cleaning.
Compared with healthy controls, COPD patients had greater
ventilatory inefﬁciency (Figure 2f) and higher ventilatory require-
ments (Figure 2b). The response to climbing stairs and placing
groceries in a cupboard was overall comparable (data not shown).
In Figure 3, individual data of DH at the end of each activity are
shown. More than half of the patients with COPD showed DH
during climbing stairs, vacuum cleaning and unloading groceries
(56%, 59% and 51%, respectively). In contrast, much less controls
demonstrated DH (10%, 10% and 35% with P= 0.002, P= 0.001
and P= 0.362, respectively). Thirty patients (77%) had DH in at
least one of the activities, compared with only eight (40%) control
subjects (P= 0.012). Fourteen patients (36%) had DH during each
ADL, compared with no controls (P= 0.006).
Within the patient group, no correlation existed between DH
during any ADL and the severity of airﬂow obstruction (expressed
as FEV1% predicted). In addition, no relation was found between
DH during the different ADL and the existence of static
hyperinﬂation at rest (RV/total lung capacity (TLC)). The amount
of DH did not show a signiﬁcant relation with increases in BORG
scores after the ADL. However, if the COPD patients were
identiﬁed as either dynamic hyperinﬂators (IC decrease during
an ADL) or non-dynamic hyperinﬂators (no IC decrease), the
hyperinﬂators scored higher increases in BORG scores compared
with non-hyperinﬂators after both stair climbing (2.9 ± 1.0 versus
2.0 ± 1.0, P= 0.03) and vacuum cleaning (1.9 ± 0.8 versus 1.2 ± 0.7,
P= 0.04).
Physical activity
Although the above-mentioned physiological differences in the
performance of ADL were found, the total group of patients with
COPD did not differ signiﬁcantly from healthy controls according
to physical activity (74 ± 21 vector magnitude units (v.m.u.) versus
80± 24 v.m.u., P= 0.273); see Figure 4. The COPD patients had a
mean physical activity similar to the lower limit of normal range
(74) for this age group (normal range 74–102).
A decreased FEV1% predicted or the occurrence of DH could not
be associated with physical inactivity within these study groups.
Health status
Finally, many of these early-stage COPD patients scored mild or
severe problems in the sub-domains of the Nijmegen Clinical
Screening Instrument (NCSI). In Figure 5, it is shown that in the
domains of Symptoms and Functional Impairments these COPD
patients score signiﬁcantly more mild and severe problems than
the healthy controls. No differences in the domain of Quality of
Life were observed.
Figure 1. Lung volumes at rest and during exercise in healthy
subjects and in patients with chronic obstructive pulmonary disease
(COPD). In normal lungs, end-expiratory lung volume (EELV) remains
relatively constant during exercise, as tidal volume can increase and
inspiratory capacity (IC) is maintained. Patients with COPD breathe
with a greater EELV and less IC. During exercise, as ventilation
increases, the increased EELV (dynamic hyperinﬂation) pushes tidal
volume closer to total lung capacity (TLC) where expansion is
limited by high pressures. IC decreases and breathing becomes so
restricted that patients have to stop activity. IRV, inspiratory reserve
volume; RV, residual volume. From ref. 30 with permission.
Table 1. Subject characteristics, lung function and pulmonary
medication
Controls (n=20) COPD (n= 39)
Age, years 62± 8 64± 8
Gender, m/f 10/10 25/14
BMI, kg/m2 25.9± 4.9 27.4± 5.2




MRC, 0/1/2/3 12/8/0/0 3/18/16/2***
FEV1, l
a 3.25± 0.85 2.58± 0.57**
FEV1, %pred 112± 15 88± 12
***
FEV1/VC, %
a 75± 4 58± 7***
TLC, %pred 109± 11 116± 13*
RV/TLC, % 37± 8 41± 6*






Combined ICS/LABA 0% 31%
No inhalation medication 100% 28%
Abbreviations: BMI, body mass index; f, female; FEV1, forced expiratory
volume in 1 s; ICS, inhaled corticosteroid; LABA, long-acting β2-agonist;
LAMA, long-acting muscarinic antagonist; m, male; pred, predicted;
RV, residual volume; SABA, short-acting β2-agonist; SAMA, short-acting
muscarinic antagonist; TLC, total lung capacity; VC, vital capacity.
apost-bronchodilator values for patients with COPD.
*Po0.05, **Po0.01, ***Po0.001 compared with controls.
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DISCUSSION
Main ﬁndings
Performing common ADL has been shown to result in a higher
ventilatory demand (VE), less ventilatory efﬁciency (VE/VCO2),
frequent occurrence of DH and higher dyspnoea scores in early-
stage COPD patients compared with healthy subjects. This group
of COPD patients with relatively preserved airﬂow were overall
normal physically active but, already very early in the disease their
health status, had declined compared with healthy subjects of the
same age. In particular, symptoms (i.e., dyspnoea and fatigue) and
functional impairment were already reported as mildly-to-severely
affected by about two-thirds of the patients.
Interpretation of ﬁndings in relation to previously published work
Ventilatory requirements have been consistently elevated for
different exercise intensities in patients with mild COPD relative to
controls.5,9,12 The present study demonstrated that even during
simple and common ADL, these patients experience a higher
ventilatory demand compared with healthy controls. In agreement
with other studies on respiratory mechanics in COPD, it is now
shown that early-stage COPD patients already breathe with
greater ventilatory inefﬁciency during ADL, as reﬂected by an
increased ventilatory equivalent for CO2.
4,5,9,12 Recently, the
mechanisms of high VE/VCO2 in mild COPD and its impact on
dyspnoea and exercise intolerance were studied during incre-
mental exercise testing with invasive arterial blood sampling.4 The
investigators found pulmonary gas-exchange abnormalities (phy-
siological dead space and wasted ventilation) in mild COPD but
still found arterial blood–gas homeostasis. They suggested that
this arterial blood–gas homeostasis is a result of compensatory
increase in minute ventilation. In addition, the higher ventilator
demand in the presence of expiratory ﬂow limitation (dynamic
hyperinﬂation at high-intensity exercise) forced earlier mechanical
constraints on tidal volume expansion and was associated with an
earlier onset of severe dyspnoea in the mild-COPD group
compared with controls. Our study used ADL without invasive
blood–gas measurements, but these former ﬁndings support the
early-respiratory changes found in our study, even in ADL. The
present study demonstrates for the ﬁrst time that dynamic
hyperinﬂation occurs during ADL in COPD patients with still
relatively preserved airﬂow. The respiratory phenomenon
DH has been described earlier in mild-COPD patients after
cardiopulmonary exercise testing (CPET)5 or after metronome-
paced hyperinﬂation.21,22 Although there was a variety in the
amount of DH within the group, our early-stage COPD and also
between the different ADL activities, the proportion of hyperin-
ﬂators in the COPD group was striking. The COPD patients
complained about more dyspnoea, which is well-understandable
because of the elevated ventilatory demand and inefﬁciency, and
consisted with the earlier mentioned mechanistic study in mild
COPD.4 However, more importantly, those patients who devel-
oped DH during ADL also experienced more dyspnoea compared
with the patients who did not develop DH. This indicates a
potential role for DH in the development of dyspnoea sensation23
during everyday activities, even in this early stage of the disease.
In contrast to the present ﬁndings, previous research in patients
from the whole GOLD spectrum (I to IV) has shown that the
amount of DH is associated with the amount of daily physical
activity.24,25 There might be several reasons why we were not able
to ﬁnd this. First, physical inactivity was a secondary outcome of
the present study, which thus lacks the power to provide
signiﬁcant results. Second, the difference in severity of airﬂow
limitation has an important role in the contrasting results. The
majority of the patients of the current study were included from
general practice, who still had a normal level of activity, indicating
another type of patients compared with the earlier studies.6
Quite recently, consensus was obtained about the value of
assessment of physical activity and health status in patients with
COPD as a clinical outcome in the management of COPD.26
A recent European cross-sectional study27 showed that patients
with mild airﬂow obstruction already display signiﬁcant health
status impairment. The present study underlines these ﬁndings
and emphasises that 55–84% of all COPD patients with relatively
preserved airﬂow limitation already experience moderate-to-
severe problems on dyspnoea sensation, fatigue and functional
impairment because of their COPD. This was in large contrast with
only 5–25% of the healthy controls having problems in their
health status.
Strengths and limitations of this study
Because of the observational and cross-sectional characteristics of
the current study, no causal relations (in)activity and health status
could be studied. However, the physiological agreements
between the present ﬁndings and other mechanistic studies
suggest also similarities in causality of the constraints and their
consequences.
Even when included in primary care, it is plausible that patients
are diagnosed with their disease based on health problems
interfering with health status (as many others are not diagnosed).
Table 2. Physiological responses to ADL
Climbing stairs Vacuum cleaning Cupboard
COPD Controls COPD Controls COPD Controls
VO2, l/min 1.3± 0.3 1.4± 0.3 0.9± 0.2 0.9± 0.2 1.3± 0.3 1.3± 0.2
VO2, %peak 71± 15 67± 16 47± 13 40± 12 69± 15 62± 16
VE, l/min 37± 7* 31± 8 27± 6* 23± 6 36± 8* 29± 6
VE, %MVV 39± 11*** 26± 9 28± 7*** 20± 7 37± 10*** 25± 8
Bf, per min 24± 6 21± 4 24± 5 23± 4 24± 6* 21± 6
Vt, l 1.65± 0.40 1.55± 0.28 1.17± 0.32 1.06± 0.21 1.61± 0.56 1.64± 0.49
VE/VCO2 35± 6
** 30± 4 36± 6** 32± 4 30± 4 35± 5**
IRV, l 1.54± 0.59 1.62± 0.60 2.00± 0.67 2.07± 0.65 1.56± 0.54 1.37± 0.54
ΔIC, l − 0.06± 0.31** 0.18± 0.20 − 0.06± 0.33** 0.25± 0.23 − 0.04± 0.29 0.09± 0.05
ΔIC, %ICrest − 1.2± 10.3** 6.5± 7.0 − 1.4± 10.4** 8.6± 6.9 − 0.5± 8.7 3.6± 7.0
BORG, dyspnoea 2.6± 1.5*** 0.8± 1.4 1.5± 1.4*** 0.5± 0.7 2.3± 1.5*** 0.6± 0.8
Time, s 46± 9 43± 6 300± 0 300± 0 81± 13** 70±14
Abbreviations: Bf, breathing frequency; IC, inspiratory capacity; IRV, inspiratory reserve volume; MVV, maximal voluntary ventilation; VE, ventilation;
VO2, oxygen consumption; Vt, tidal volume.
*Po0.05 compared with controls; **Po0.01 compared with controls; ***Po0.001 compared with controls.
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In other words, a selection bias might have increased the
proportion of patients with impaired health status in this study
population.
In the study design, it was chosen to study ADL that are
commonly performed by the included patients. Hereby, the usual
activities and constraints of patients are reﬂected, which strength-
ens this study. For the ﬁrst time, COPD patients with relatively
preserved airﬂow from general practice were studied on breathing
mechanics during usual activities. Furthermore, the study also
underlined the occurrence of limitations in patient-related out-
comes in these early stages of the disease.
Implications for future research, policy and practice
The effect of treatment on ventilatory constraints in these early-
stage COPD patients was beyond the scope of this study.
Exploratory studies suggest that pharmacotherapy has beneﬁcial
effects on airway physiology in patients with COPD (reviewed in
refs 28–31). However, the clinical relevance of these improve-
ments remains to be determined. The current ﬁndings again open
the discussion whether and when therapy in COPD should
be started. Appropriate clinical trials are needed to evaluate
the efﬁcacy proﬁle of various pharmacological and non-
pharmacological interventions for the management of patients
with mild COPD. Next, the natural course of the different
ventilatory constraints found in this study remains unclear. An
earlier study21 suggests that DH worsens at a higher speed than
the airﬂow limitation of COPD patients, indicating the importance
of early screening for DH. The current study indicates a potential
role for this dynamic respiratory mechanic impairment in the
development of dyspnoea sensation during ADL, even in this early
stage of the disease. Clearly, prospective studies on DH, its
Figure 2. Metabolic and ventilatory responses to vacuum cleaning. (a) Oxygen uptake (VO2), (b) minute ventilation (VE), (c) respiratory
frequency (fR), (d) tidal volume (Vt), (e) inspiratory time (Ti) and expiratory time (Te) and (f) VE/carbon dioxide production (VCO2). Data are
presented as mean± s.e.m. *Po0.05 at standardised time points.
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consequences for the patients and eventually the effect of early
treatment of DH are needed.
Finally, even patients in these early stages of COPD and with still
relatively preserved airﬂow already decline their activity levels to
the lower limit of normal, reﬂecting the importance of early
recognition of the illness and encouragement of physical
activity and exercise in mild COPD. Awareness and assessment
of physical (in)activity in COPD within general practice deserves
high attention.
Conclusions
The results of this study show elevated ventilatory requirement
and ventilatory inefﬁciency together with dynamic hyperinﬂation
in early-stage COPD patients during the performance of simple
and common ADL, resulting in more dyspnoea compared with
healthy controls. In addition, patients who develop DH during ADL
also experience more dyspnoea than patients without DH,
reﬂecting a potential role of this respiratory limitation in dyspnoea
sensation, even in mild COPD patients performing easy ADL.
Although the patients from general practices in this study still had
a normal physical activity level, a very large proportion of these
COPD patients already experienced limitations in health status.
These results reinforce the importance of early diagnosis of COPD
in general practices and assessment of more than just spirometry.
The fact that ventilatory constraints in these mild patients already
occur during commonly performed ADL opens again the
discussion of early treatment in COPD.
MATERIALS AND METHODS
Subjects
Forty patients with stable COPD and relatively preserved airﬂow
(FEV1/VCo0.7, FEV1⩾ 65% of predicted after bronchodilation) were
included. In this study, patients with an FEV1465 of predicted were
included as early-stage COPD patients, and thus reﬂect the group of GOLD
I and the mildest half of GOLD II COPD patients, according to the GOLD
initiative.1 Patients were recruited from general practices in or close to
Nijmegen and from the outpatient population of Radboud university
medical center or university center for chronic diseases Dekkerswald.
Exclusion criteria were co-existing lung diseases other than COPD
(including asthma) and exercise-limiting disorders other than COPD such
as cardiac or neuromuscular disease.
In addition, 20 non-obstructive control subjects, aged 40–80 years,
without a history of lung diseases were recruited from the same region as
the patients. Exclusion criteria for this control group were disorders
causing exercise limitation or inﬂuencing physical activity (e.g., neuromus-
cular or skeletal disorders). Healthy subjects who were highly active
(performing sport activities 43 × a week) were also excluded.
Study design
Subjects visited our laboratory on 2 days. During the ﬁrst visit, pulmonary
function tests and anthropometrics were performed. Ventilatory and
metabolic constraints were measured during the performance of three
different ADL. In addition, assessment of physical activity for 7–10 days
began. During the second visit (maximal 8 days after visit 1), a CPET was
performed and health status was assessed.
This study was conducted in accordance with the amended Declaration
of Helsinki and was approved by the local medical ethics committee
(CMO Arnhem-Nijmegen, no NL37406.091.11 and NL42423.091.12). All
subjects gave their written informed consent.
ADL measurements
Subjects performed three ADL in a randomised order at their usual pace:
climbing stairs (A), vacuum cleaning (B) and placing groceries in a
cupboard (C). During ADL-A, subjects climbed 2 ﬂoors (39 steps in total).
During ADL-B, subjects were asked to vacuum a carpet for 5 min the way
they usually do (same position and speed). In addition, subjects displaced
10 products of 1 kg one by one from a ground shelf to a shelf at shoulder
height and back (ADL-C). The activities were ﬁnished after task completion
or until symptom limitation. During the activities, a portable breath-by-
breath system (Oxycon Mobile, Jaeger, CareFusion GmbH, Hoechberg,
Germany) was used to measure metabolic and ventilatory parameters
including inspiratory capacity (IC) to reﬂect dynamic hyperinﬂation.32
IC manoeuvers were directly visible for the investigators and were
performed at rest and directly after each activity sitting upright. Dynamic
hyperinﬂation was expressed as the decrease in IC relative to resting IC
(%ΔIC = (IC end− IC rest)/IC rest × 100) and/or as absolute change in IC
(IC end− IC rest). Shortness of breath was rated using the modiﬁed Borg
scale (0–10) at the start and end of each ADL.
Pulmonary function, exercise capacity, physical activity and health
status
Spirometry and body plethysmography were performed according to the
American Thoracic Society/European Respiratory Society guidelines.33,34
Predicted normal values were derived from the European Community for
Steel and Coal.35 Predicted normal values for IC were calculated as
predicted TLC minus predicted functional residual capacity (FRC). Each
subject completed a symptom-limited incremental CPET on a cycle
ergometer to determine peak oxygen consumption according to the
ATS/ACCP guidelines.36 Tests consisted of steady-state unloaded cycling
for 3 min followed by 5–20 W increase in work rate every minute untill
Figure 3. Dynamic hyperinﬂation (DH), expressed as change in IC, after different ADL. (a) Stair climbing, (b) vacuum cleaning and (c) displacing
groceries in a cupboard. Percentages indicate proportion of subjects demonstrating a decrease in IC (hyperinﬂators).
Figure 4. Mean physical activity of healthy controls compared with
COPD. No signiﬁcant differences were seen.
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symptom limitation. Subjects cycled on an electrically braked cycle
ergometer (Masterlab, Jaeger, Wurzburg, Germany) while breathing
through a face mask that was connected to a metabolic system (Oxycon
Pro). Measurements included standard breath-by-breath cardiorespiratory
and breathing pattern parameters; oxygen saturation by pulse oximetry;
heart rate by ECG and dyspnoea intensity assessed with the modiﬁed
10-point Borg scale.
To assess daily physical activity, subjects wore a tri-axial accelerometer
(Actometer, manufactured by the Department of Electronics and Instru-
ment Services of the Psychological Laboratory of the University of
Nijmegen, the Netherlands) at the ankle for at least 7 consecutive days and
nights.37 Mean daily activity was expressed as v.m.u.
Health status was assessed by the NCSI.38
Statistical analysis
This was an observational physiological study with the main outcome
measures consisting of VE, VE/VCO2, VT, Bf and DH. Because of the complex
and time-consuming ADL measurements, we planned to include 40
patients and 20 healthy controls. Data of one COPD patient were not
reliable and thereby excluded from analyses. In previous studies5,12,39
incorporating physiological measurements during ADL and other exercises,
this sample size was large enough to detect signiﬁcant difference in
relevant physiological variables.
Baseline characteristics are shown as mean± s.d. or as frequencies.
Between-group comparisons of subject characteristics and physiological
variables at standardised point during ADL were performed using unpaired
Student’s t-test. In case of unequal variances or distributions (pack-years,
MRC, ΔIC and physical activity), Mann–Whitney tests were used. To test
differences in occurrence of dynamic hyperinﬂation and other categorical
variables between patients and controls, the Χ2-test was used. Associations
between lung function, ADL physiology, dyspnoea and physical activity
were determined using Spearman's correlations.
Po0.05 was indicated as statistically signiﬁcant. Data were analysed
with SPSS 20.0 (IBM Corp, Armonk, NY, USA).
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